Neuromuscular Monitoring

Quick Answer

Neuromuscular monitoring quantitatively assesses the degree of neuromuscular blockade (NMB) by electrically stimulating a peripheral motor nerve and measuring the evoked muscle response. The train-of-four (TOF) ratio is the primary clinical endpoint, with TOF ratio ≥0.9 required before extubation to ensure safe recovery and prevent residual postoperative neuromuscular blockade (RNMB).

High-Yield Exam Points:

Clinical Applications: Intraoperative depth assessment, reversal agent timing, confirming adequate recovery before extubation, and research standardisation. Current guidelines mandate quantitative monitoring with documentation of TOF ratio ≥0.9 before extubation. [1-5]

---

Rationale for Monitoring

The Problem of Residual Neuromuscular Blockade

Residual neuromuscular blockade (RNMB) is defined as TOF ratio <0.9 at the time of extubation or in the post-anaesthesia care unit. This represents one of the most preventable causes of postoperative respiratory complications.

Incidence of RNMB:

The landmark RECITE study demonstrated that even with contemporary practice, 63.5% of patients had TOF ratio <0.9 upon arrival in PACU when quantitative monitoring was not routinely used. [6]

Consequences of RNMB

Patients with TOF ratio <0.9 experience clinically significant impairment across multiple systems:

Respiratory Consequences:

• Upper airway obstruction from pharyngeal muscle weakness
• Impaired swallowing coordination (aspiration risk)
• Reduced hypoxic ventilatory drive (blunted response to hypoxia)
• Decreased forced vital capacity and peak expiratory flow
• Atelectasis and hypoxaemia

Clinical Evidence:

• TOF ratio 0.7-0.9: 4-fold increased risk of critical respiratory events [7]
• TOF ratio <0.7: Upper oesophageal sphincter dysfunction, aspiration demonstrated on videofluoroscopy [8]
• TOF ratio <0.9: Diplopia, facial weakness, patient-reported generalised weakness [9]

Other Consequences:

• Prolonged PACU stay and delayed discharge
• Increased ICU admission rates
• Patient distress and dissatisfaction
• Potential medicolegal implications

Why Qualitative Assessment is Insufficient

Visual and tactile assessment of TOF response cannot reliably detect fade when TOF ratio exceeds 0.4. At clinically significant ratios of 0.7-0.9, qualitative assessment fails to detect residual block in 50-70% of cases.

This limitation necessitates quantitative monitoring to ensure patient safety. [10,11]

---

Stimulation Patterns

Single Twitch Stimulation

Definition: Single supramaximal stimuli delivered at low frequency (0.1-1 Hz), comparing response amplitude to a pre-relaxant baseline (control) value.

Parameters:

• Frequency: 0.1 Hz (one stimulus every 10 seconds) or 1 Hz
• Pulse duration: 0.1-0.3 ms
• Current: Supramaximal (typically 40-60 mA)

Interpretation:

Limitations:

• Requires accurate baseline measurement before NMBA administration
• Baseline can drift with temperature, electrode position
• Cannot distinguish depolarising from non-depolarising block
• Less informative than TOF for recovery assessment
• Primarily used in research settings [12]

Train-of-Four (TOF) Stimulation

Definition: Four supramaximal stimuli delivered at 2 Hz frequency (one stimulus every 0.5 seconds) over 1.5 seconds total.

Physics Parameters:

• Frequency: 2 Hz (period = 500 ms between stimuli)
• Number of stimuli: 4
• Total duration: 1.5 seconds
• Repeat interval: Minimum 10-15 seconds between TOF sequences
• Current: Supramaximal

Responses Measured:

1. TOF Count: Number of visible/palpable twitches (0-4)
2. TOF Ratio: Amplitude of T4 ÷ amplitude of T1 (0-1.0)

Interpretation:

Fade Phenomenon:

With non-depolarising NMBAs, successive responses progressively decrease (T1 > T2 > T3 > T4). This "fade" results from:

1. Prejunctional nicotinic receptor blockade - Reduced ACh mobilisation
2. Decreased acetylcholine release per stimulus
3. Postjunctional receptor desensitisation

The ratio T4/T1 quantifies fade and correlates with clinical recovery.

Advantages of TOF:

• No baseline measurement required
• Self-referencing (compares T4 to T1 within same sequence)
• Distinguishes depolarising (no fade) from non-depolarising block (fade present)
• Correlates with clinical recovery [13,14]

Tetanic Stimulation

Definition: Continuous train of stimuli at high frequency (typically 50 Hz) for a defined duration (usually 5 seconds).

Parameters:

• Frequency: 50 Hz (standard), 30-200 Hz (research)
• Duration: 5 seconds
• Current: Supramaximal

Responses:

• No block: Sustained contraction throughout tetanus
• Non-depolarising block: Contraction fades during tetanus
• Depolarising block (Phase I): Sustained response (no fade)
• Depolarising block (Phase II): Fade appears (resembles non-depolarising)

Clinical Applications:

1. Assessment of sustained muscle response
2. Component of post-tetanic count protocol
3. Evaluation of complete reversal

Post-Tetanic Potentiation: Following tetanus, subsequent twitches are transiently enhanced due to:

• Increased calcium accumulation in nerve terminal
• Enhanced acetylcholine mobilisation
• Increased probability of vesicle release per stimulus

Important: Wait 5-6 minutes after tetanus before resuming TOF monitoring to avoid confounding from post-tetanic potentiation. [15]

Post-Tetanic Count (PTC)

Definition: A method for assessing deep neuromuscular blockade when TOF count = 0, exploiting post-tetanic facilitation.

Technique:

1. Confirm TOF count = 0
2. Deliver 5-second tetanic stimulation at 50 Hz
3. Wait 3 seconds
4. Deliver single twitch stimuli at 1 Hz
5. Count the number of post-tetanic twitches (PTC)

Mechanism of Post-Tetanic Facilitation:

During intense block, tetanic stimulation:

1. Causes massive ACh release and depletion
2. Triggers calcium accumulation in nerve terminal
3. Stimulates compensatory ACh synthesis and mobilisation
4. Following tetanus, enhanced ACh release transiently overcomes deep block
5. Produces detectable twitches when TOF would show zero

Clinical Interpretation:

Caveats:

• PTC depletes ACh stores; repeat no more frequently than every 3-6 minutes
• Inter-patient variability is significant
• Correlation with surgical conditions, not precise reversal timing
• Recovery time varies with drug, dose, patient factors [16,17]

Double-Burst Stimulation (DBS)

Definition: Two short bursts of tetanic stimulation (50 Hz) separated by 750 ms, each burst consisting of 2-3 stimuli.

Patterns:

• DBS3,3: Two bursts of 3 stimuli each at 50 Hz, 750 ms apart
• DBS3,2: First burst 3 stimuli, second burst 2 stimuli

Purpose:

• Detects residual block (TOF ratio 0.6-0.9) more sensitively than tactile TOF assessment
• Produces two distinct muscle responses easier to compare subjectively
• Improved manual detection of fade compared to 4 successive twitches

Comparison with TOF:

Limitation: DBS cannot replace quantitative monitoring. Manual assessment still misses residual block at TOF ratio 0.7-0.9 in many cases. [18,19]

---

Train-of-Four (TOF) Interpretation

TOF Ratio: The Recovery Criterion

Why TOF Ratio ≥0.9?

The TOF ratio 0.9 threshold is supported by extensive clinical and physiological evidence:

Historical Context:

The previous criterion of TOF ratio 0.7 was based on older studies measuring gross respiratory parameters (tidal volume, minute ventilation). Modern investigation using more sensitive measures (pharyngeal function, swallowing coordination, hypoxic ventilatory drive) revealed significant deficits persisting at ratios 0.7-0.9.

Current Standard: TOF ratio ≥0.9 is universally accepted as the minimum for safe extubation. Some authorities recommend ≥0.95 or ≥1.0 when using acceleromyography due to potential overestimation. [20,21]

Fade vs No Fade

Phase II block (dual block) develops with prolonged or repeated succinylcholine administration and resembles non-depolarising block. [22]

---

Post-Tetanic Count (Deep Block Assessment)

When to Use PTC

PTC is indicated when:

• TOF count = 0 (no visible twitches)
• Need to assess depth of intense/deep block
• Surgical requirement for profound relaxation
• Planning timing of reversal

Surgical Applications of Deep Block

Evidence suggests deep block (PTC 1-2) improves surgical conditions for laparoscopy, allowing lower insufflation pressures and reduced postoperative pain. [23,24]

---

Double-Burst Stimulation (Detecting Fade)

Clinical Utility

DBS was developed to improve manual (tactile/visual) detection of residual block. The two responses are easier to compare than four successive TOF twitches.

Efficacy of Fade Detection:

Conclusion: While DBS improves tactile fade detection compared to TOF, neither method reliably excludes clinically significant residual block (TOF ratio 0.7-0.9). Quantitative monitoring remains essential. [25]

---

Electrode Placement

Ulnar Nerve at Wrist (Gold Standard)

Anatomical Location:

• 2-3 cm proximal to wrist crease
• Between flexor carpi ulnaris tendon (ulnar side) and palmaris longus tendon (radial side)
• Nerve lies superficially at this location

Electrode Configuration:

• Cathode (negative, black): Placed distally, directly over nerve
• Anode (positive, red): Placed 2-3 cm proximal to cathode
• Rationale: Lower depolarisation threshold at cathode; current flows from anode to cathode

Monitored Muscle:

• Adductor pollicis: Innervated by ulnar nerve (C8-T1)
• Action: Adducts thumb toward palm
• Response measured: Thumb movement (AMG), force of adduction (MMG), or CMAP (EMG)

Why Adductor Pollicis?

• Recovers more slowly than diaphragm and laryngeal muscles
• Provides safety margin: if peripheral recovery adequate, respiratory muscles are recovered
• Well-studied correlation with clinical outcomes
• Accessible and easy to monitor [26]

Facial Nerve (Alternative Site)

Location:

• Anterior to tragus of ear
• Stimulates facial nerve branches

Monitored Muscles:

• Orbicularis oculi (eye closure)
• Corrugator supercilii (brow movement)

Characteristics:

• Faster onset: Reflects central muscle blood flow
• Faster recovery: Recovers before adductor pollicis
• Less reliable: Does not provide same safety margin
• Useful when: Arms inaccessible, lateral position

Important: Facial nerve monitoring should NOT be used to determine readiness for extubation because it recovers before peripheral muscles. [27]

Other Sites

---

Qualitative vs Quantitative Monitoring

Qualitative Assessment

Methods:

• Visual observation of muscle twitch
• Tactile palpation of muscle contraction

Capabilities:

• TOF count (number of twitches)
• Presence or absence of gross fade
• Adequate for assessing onset and moderate block

Limitations:

• Cannot measure TOF ratio
• Cannot reliably detect fade when TOF ratio >0.4
• High inter-observer variability
• Cannot determine readiness for extubation

Quantitative Monitoring

Methods:

• Acceleromyography (AMG)
• Electromyography (EMG)
• Mechanomyography (MMG) - gold standard
• Kinemyometry (KMG)

Capabilities:

• Objective TOF ratio measurement
• Documented recovery confirmation
• Reliable detection of residual block
• Research standardisation

Current Recommendations: All major guidelines now recommend or mandate quantitative monitoring when NMBAs are used. The 2023 ASA Practice Guidelines explicitly recommend quantitative monitoring with TOF ratio ≥0.9 confirmation before extubation. [28,29]

---

Quantitative Monitors

Acceleromyography (AMG)

Principle: Newton's second law: F = ma. For a fixed mass (thumb), acceleration is proportional to force. A piezoelectric transducer on the thumb generates voltage proportional to acceleration.

Components:

1. Piezoelectric sensor mounted on thumb
2. Hand adapter immobilising hand with thumb free
3. Processing unit calculating TOF ratio

Devices:

• TOF-Watch (historical gold standard for AMG)
• TOF-Scan (current)
• Stimpod NMS 450
• IntelliVue NMT (Philips, integrated monitor)
• TOF-Cuff (measures at adductor pollicis via cuff)

Advantages:

• Quantitative TOF ratio
• Portable, relatively inexpensive
• Easy setup (2-5 minutes)
• Objective, documented

Limitations:

1. Requires free thumb movement
2. Arm must be supinated and immobilised
3. Calibration required (may drift)
4. Overestimates recovery: AMG TOF 1.0 may equal MMG 0.9
5. Variability between devices
6. Affected by movement artifact

AMG-Specific Considerations:

• Calibration (CAL2) performed after induction, before NMBA
• Baseline TOF ratio may exceed 1.0 (supraphysiologic)
• Normalised ratio preferred
• Some recommend AMG TOF ≥0.95-1.0 for extubation [30,31]

Kinemyometry (KMG)

Principle: Measures thumb displacement/movement using a sensor that detects positional change rather than acceleration.

Advantages:

• Quantitative measurement
• May be less affected by movement artifact than AMG
• Provides displacement curves

Limitations:

• Less widely available than AMG
• Also requires free thumb movement
• Limited comparative data

Electromyography (EMG)

Principle: Records compound muscle action potential (CMAP) directly from stimulated muscle fibres. Measures electrical activity rather than mechanical response.

Components:

1. Stimulating electrodes over ulnar nerve
2. Recording electrodes over thenar/hypothenar eminence
3. Reference electrode on hand/forearm
4. Amplifier and signal processor

Devices:

• GE Datex-Ohmeda NMT module
• Draeger NMT module

Advantages:

• Direct electrical measurement
• Can be used when thumb movement restricted
• Good correlation with MMG
• Can monitor multiple sites
• Less position-sensitive than AMG

Limitations:

• More complex setup
• Sensitive to electrical interference (diathermy, 50 Hz mains)
• Electrode position critical
• More expensive than AMG [32,33]

Mechanomyography (MMG) - Gold Standard

Principle: Directly measures isometric force of muscle contraction using a force transducer. The thumb is fixed against a strain gauge.

Components:

1. Force transducer (strain gauge)
2. Preload device (constant baseline tension)
3. Rigid arm board and fixation
4. Recording system

Why Gold Standard:

1. Directly measures force of contraction (what we want to know)
2. Highly reproducible and accurate
3. Reference for validating all other methods
4. Linear relationship with receptor occupancy
5. Established clinical outcome correlations

Limitations:

1. Complex setup (15-20 minutes)
2. Bulky equipment
3. Rigid arm fixation required
4. Arm must be accessible throughout
5. Expensive
6. Impractical for routine clinical use

Use: Research, validation studies, pharmacological investigations. [34,35]

Comparison of Methods

---

Calibration and Standards

Calibration Principles

Purpose: Establish baseline response before NMBA administration for accurate subsequent measurements.

Timing: After induction, before NMBA, when stable conditions achieved.

Process:

1. Apply electrodes, position hand
2. Deliver test stimuli at increasing current
3. Identify supramaximal current (plateau response + 20-25%)
4. Record baseline T1 amplitude and TOF ratio
5. Store calibration values

AMG Calibration:

• Most devices use automatic calibration (CAL2)
• Baseline TOF ratio often >1.0 (supraphysiologic staircase effect)
• Normalisation: express current TOF ratio as proportion of baseline

Standardisation Requirements

Good Clinical Research Practice (GCRP) recommendations for neuromuscular studies:

The Stockholm revision of GCRP guidelines provides detailed methodology for research studies. [36]

---

Factors Affecting Monitoring

Temperature

Effect: Hypothermia prolongs neuromuscular block and affects monitoring.

Mechanism:

• Decreased ACh release at low temperature
• Reduced nerve conduction velocity
• Altered drug pharmacokinetics (reduced clearance)
• Direct muscle contractile impairment

Recommendation: Maintain monitoring site temperature >35°C. Central core temperature <35.5°C associated with prolonged block. [37]

Electrode Placement

Factors affecting current delivery:

Patient Factors

Drug Interactions Affecting Block

---

Clinical Targets

TOF Ratio ≥0.9 for Extubation

Evidence Summary:

Implementation:

1. Use quantitative monitoring for all cases with NMBA
2. Document TOF ratio before reversal decision
3. Administer appropriate reversal agent
4. Confirm TOF ratio ≥0.9 before extubation
5. Document final TOF ratio in anaesthetic record

Targets for Specific Situations

---

Evidence for Monitoring

Systematic Reviews and Meta-Analyses

Cochrane Review (Naguib et al., 2007): Meta-analysis demonstrated residual paralysis (TOF <0.9) in 41% of patients receiving intermediate-acting NMBAs without quantitative monitoring. Quantitative monitoring reduced this to approximately 5-10%. [38]

Murphy et al. (2011): Systematic review found acceleromyography monitoring reduced incidence of RNMB and improved quality of recovery in early postoperative period. [39]

Key Trials

POPULAR Trial (2023): Prospective observational study in 22,803 patients. Found that 4.4% of patients without NMBAs developed postoperative pulmonary complications (PPCs) compared with 5.7% with NMBAs. Risk was mitigated when reversal was guided by quantitative monitoring and TOF ratio ≥0.9 was achieved. [40]

RECITE Study (2015): Canadian multicentre study demonstrating 63.5% of patients had TOF <0.9 on PACU arrival despite clinical reversal. Confirmed the inadequacy of qualitative assessment and clinical criteria alone. [41]

Murphy et al. (2008): Landmark study showing TOF ratio 0.7-0.9 associated with 4-fold increase in critical respiratory events requiring intervention (airway obstruction, hypoxaemia, reintubation). [7]

Quality of Evidence

The evidence supporting quantitative monitoring is high quality:

• Multiple RCTs demonstrating reduced RNMB
• Prospective observational studies confirming harm from RNMB
• Physiological studies demonstrating impairment at TOF 0.7-0.9
• Consensus from all major anaesthesia societies

---

Current Guidelines

ASA 2023 Practice Guidelines

The American Society of Anesthesiologists 2023 guidelines represent the most comprehensive evidence-based recommendations:

Key Recommendations:

1. Quantitative neuromuscular monitoring recommended when NMBAs administered
2. TOF ratio ≥0.9 should be achieved before extubation
3. Qualitative monitoring alone is insufficient for determining recovery
4. Reversal agents should be administered based on monitoring
5. Documentation of neuromuscular function before extubation recommended

ANZCA PS18 Guidelines

Australian and New Zealand College of Anaesthetists guidelines state:

• Neuromuscular function monitoring should be available when NMBAs used
• Quantitative monitoring is recommended for assessing adequacy of reversal
• TOF ratio ≥0.9 is the accepted criterion for safe extubation

International Consensus Statement (2018)

Expert consensus (Naguib et al.) recommendations:

1. Quantitative monitoring should be used whenever NMBAs administered
2. TOF ratio ≥0.9 documented before tracheal extubation
3. Qualitative monitoring (tactile/visual) is inadequate
4. Training in neuromuscular monitoring should be standard
5. Reversal agents should be routinely administered unless TOF ratio already ≥0.9 [29]

Mandatory Monitoring Recommendations

Several professional societies now mandate quantitative monitoring:

• European Society of Anaesthesiology (ESA)
• German Society of Anaesthesiology (DGAI)
• Difficult Airway Society (DAS) guidelines for extubation

---

Indigenous Health Considerations

Australian Context: Aboriginal and Torres Strait Islander Populations

Aboriginal and Torres Strait Islander patients requiring surgery with neuromuscular blockade may face unique challenges affecting neuromuscular monitoring and recovery.

Access to Quantitative Monitoring:

Remote and rural health services, where Indigenous Australians are disproportionately represented, may have limited access to quantitative neuromuscular monitors. Standard acceleromyography devices require calibration, maintenance, and staff training that may be inconsistent in smaller facilities. Point-of-care anaesthesia services during outreach surgical programs may rely on qualitative assessment alone, increasing the risk of residual neuromuscular blockade.

Physiological Considerations:

Higher rates of diabetes mellitus, chronic kidney disease (CKD), and obesity in Indigenous populations alter NMBA pharmacokinetics:

• Chronic kidney disease: 3-4 times higher prevalence; prolongs aminosteroidal agents (rocuronium, vecuronium) duration
• Diabetes mellitus: May cause autonomic and peripheral neuropathy affecting neuromuscular function and monitoring reliability
• Obesity: Increases volume of distribution; dosing should use ideal body weight for NMBAs but actual body weight for reversal agents

Recommendations:

• Preoperative assessment should include renal function (creatinine clearance)
• Lower threshold for quantitative monitoring in patients with CKD or diabetes
• Extended monitoring period before extubation in patients with risk factors
• Consider shorter-acting agents (cisatracurium) in renal impairment

Cultural Considerations:

Effective communication about the purpose of neuromuscular monitoring supports informed consent and patient trust. Aboriginal Hospital Liaison Officers can facilitate explanations about the "thumb twitch test" and its role in ensuring safe awakening from anaesthesia. Visual aids and plain language explanations assist when English is not the first language. Family involvement in perioperative discussions respects collective decision-making valued in many Indigenous communities.

New Zealand Context: Māori Health

Māori patients have higher rates of type 2 diabetes (2-3 times non-Māori) and chronic kidney disease, which influence NMBA pharmacology and monitoring requirements. Whānau (extended family) involvement in perioperative care decisions aligns with tikanga (correct protocols) and supports culturally safe practice.

Rural hospitals serving communities with high Māori populations may have variable access to modern quantitative monitoring equipment due to funding constraints. The principles of manaakitanga (hospitality, care) and patient-centred communication guide culturally appropriate anaesthesia practice, including clear explanation of monitoring technology and its purpose in ensuring patient safety.

---

Assessment Content

SAQ Practice Question (20 marks)

Question:

A 62-year-old man (90 kg, BMI 32) with chronic kidney disease (eGFR 35 mL/min/1.73m²) undergoes emergency laparotomy for bowel obstruction. He received rocuronium 60 mg (0.67 mg/kg) for intubation and two additional doses of 20 mg during the 3-hour procedure. At the end of surgery, the TOF count is 2 with visible fade.

(a) Explain the physics principles underlying train-of-four (TOF) stimulation, including the significance of supramaximal stimulation and the interpretation of TOF count and TOF ratio. (6 marks)

(b) Describe the mechanism of "fade" observed during non-depolarising neuromuscular blockade and explain why TOF ratio ≥0.9 is the accepted criterion for safe extubation. (5 marks)

(c) Compare acceleromyography (AMG) and mechanomyography (MMG) as methods for quantitative neuromuscular monitoring. Why is AMG used clinically while MMG remains the gold standard? (5 marks)

(d) Given this patient's renal impairment and block depth, outline your approach to reversal and confirmation of adequate recovery before extubation. (4 marks)

---

Model Answer:

(a) Physics Principles of TOF Stimulation (6 marks)

TOF Pattern (2 marks):

• Four supramaximal stimuli delivered at 2 Hz frequency (one stimulus every 0.5 seconds)
• Total duration 1.5 seconds; repeat interval minimum 10-15 seconds
• Does not require baseline measurement (self-referencing: compares T4 to T1 within same sequence)

Supramaximal Stimulation (2 marks):

• Current intensity 20-25% above that producing maximal muscle response
• Ensures consistent activation of all motor nerve fibres regardless of small variations in electrode position, skin resistance, or tissue hydration
• Eliminates recruitment variability; typical current 40-60 mA
• Determined by incrementally increasing current until response plateaus, then adding 20-25%

TOF Interpretation (2 marks):

• TOF count: Number of visible/palpable twitches (0-4); correlates with receptor occupancy and block depth
• TOF ratio: Amplitude of T4 ÷ amplitude of T1; quantifies fade and correlates with clinical recovery
• Ratio requires quantitative monitoring; visual/tactile assessment cannot reliably detect fade when ratio >0.4

(b) Mechanism of Fade and TOF ≥0.9 Criterion (5 marks)

Fade Mechanism (2 marks):

• Fade results from prejunctional (presynaptic) nicotinic acetylcholine receptor blockade
• Non-depolarising NMBAs block prejunctional receptors that normally provide positive feedback for ACh mobilisation
• With repeated stimulation, ACh release progressively decreases without this feedback mechanism
• Additionally, postjunctional receptor desensitisation and reduced ACh stores contribute

Significance of TOF ≥0.9 (3 marks):

• Clinical and physiological evidence demonstrates significant impairment at TOF 0.7-0.9:
  • Upper airway obstruction and pharyngeal dysfunction
  • Impaired swallowing coordination with aspiration risk
  • Reduced hypoxic ventilatory drive
  • Patient-reported weakness and diplopia
• Previous criterion of 0.7 based on gross respiratory parameters; sensitive measures reveal persistent deficits at higher ratios
• Residual block (TOF <0.9) occurs in 20-40% without quantitative monitoring
• TOF ≥0.9 represents the threshold at which protective reflexes, respiratory function, and subjective strength are reliably restored

(c) AMG vs MMG Comparison (5 marks)

Mechanomyography - Gold Standard (2 marks):

• Directly measures isometric force of muscle contraction using strain gauge transducer
• Thumb fixed against force gauge with preload; measures what we want to know (force)
• Highly accurate, reproducible; reference standard for validating other methods
• Linear relationship with receptor occupancy; established outcome correlations
• Limitations: Complex setup (15-20 min), bulky equipment, rigid fixation required, impractical for routine clinical use

Acceleromyography - Clinical Standard (2 marks):

• Based on Newton's second law (F = ma); measures thumb acceleration via piezoelectric sensor
• For fixed mass, acceleration proportional to force
• Advantages: Portable, inexpensive, quick setup (2-5 min), quantitative TOF ratio
• Limitations: Requires free thumb movement, calibration needed, may drift during long cases

Why AMG Used Clinically (1 mark):

• Practicality: AMG provides adequate accuracy with vastly superior practicality
• AMG slightly overestimates recovery (TOF 1.0 may equal MMG 0.9); compensate by using ≥0.95 threshold or normalised ratio
• Despite limitations, AMG is vastly superior to qualitative assessment

(d) Reversal and Recovery Approach (4 marks)

Patient Considerations (1 mark):

• Chronic kidney disease (eGFR 35) prolongs rocuronium elimination (renal excretion of metabolites)
• Total rocuronium 100 mg over 3 hours; may have significant residual drug
• Higher risk of delayed recovery and RNMB

Reversal Strategy (2 marks):

• TOF count = 2: appropriate for either neostigmine or sugammadex
• Preferred: Sugammadex 2 mg/kg (180 mg)
  • Rapid, predictable reversal (2-3 min to TOF ≥0.9)
  • Encapsulates rocuronium; complex eliminated renally (prolonged but stable)
  • No muscarinic side effects
• Alternative: Neostigmine 50 mcg/kg with glycopyrrolate 10 mcg/kg
  • Acceptable at TOF count 2, but recovery may be prolonged (15-30 min)
  • Ceiling effect limits efficacy if deeper than expected

Recovery Confirmation (1 mark):

• Quantitative monitoring essential: Confirm TOF ratio ≥0.9 (or ≥0.95-1.0 for AMG)
• Do NOT rely on clinical signs (head lift, grip strength) alone; unreliable at TOF 0.7-0.9
• Document measurement before extubation
• Extended monitoring given CKD and cumulative rocuronium dose

---

Viva Scenario (15 marks)

Scenario:

You are the anaesthetist for a 55-year-old woman undergoing laparoscopic hysterectomy. The surgeon requests "good relaxation" throughout. She received rocuronium 50 mg at induction 90 minutes ago, and you are using an acceleromyography monitor.

---

Examiner: "The monitor shows TOF count of 1 and the surgeon is complaining of inadequate relaxation. How do you interpret this and what do you do?"

Candidate: "A TOF count of 1 indicates moderate-to-deep neuromuscular blockade with approximately 90-95% receptor occupancy. For optimal laparoscopic surgical conditions, deeper block with TOF count of 0 and post-tetanic count of 1-2 is often preferred as it provides better abdominal wall relaxation and may allow lower insufflation pressures.

I would administer an additional incremental dose of rocuronium, typically 10-20 mg or 0.1-0.15 mg/kg, and monitor for response. My target would be TOF count 0 with PTC 1-5 for deep block. I would reassess both the neuromuscular monitor and surgical conditions after 3-5 minutes."

---

Examiner: "Explain the physics of how your acceleromyography monitor works."

Candidate: "Acceleromyography is based on Newton's second law, which states that force equals mass times acceleration. For the thumb, which has a fixed mass, the acceleration of movement is directly proportional to the force of contraction.

The monitor uses a piezoelectric transducer attached to the thumb. Piezoelectric materials generate a voltage when subjected to mechanical stress or deformation. When the ulnar nerve is stimulated and the thumb adducts, the acceleration of thumb movement deforms the piezoelectric crystal, generating a voltage signal proportional to the acceleration and therefore proportional to the force of contraction.

The monitor processes this signal to calculate the amplitude of each twitch response. The TOF ratio is calculated by dividing the amplitude of the fourth twitch by the amplitude of the first twitch.

For accurate measurement, several conditions must be met: the stimulating current must be supramaximal to ensure all motor fibres are activated, the thumb must be free to move without restriction, the hand should be supinated and immobilised to prevent movement artifact, and the monitor should be calibrated before NMBA administration to establish a baseline."

---

Examiner: "What is supramaximal stimulation and why is it important?"

Candidate: "Supramaximal stimulation means using a current intensity 20 to 25 percent above the level that produces the maximal evoked muscle response.

It is important for three reasons. First, it ensures reproducibility: all motor nerve fibres are consistently activated with every stimulus, regardless of small variations in electrode position, skin resistance, or tissue hydration over time.

Second, it achieves all-or-none recruitment: at supramaximal current, every motor unit innervated by the stimulated nerve is recruited. There is no variability from incomplete recruitment that would occur at lower current levels.

Third, it provides accurate assessment: if submaximal stimulation were used, the evoked response would underestimate the true degree of neuromuscular blockade because not all motor units would be contributing.

In practice, supramaximal current is determined by gradually increasing current from a low level, such as 10-15 milliamps, in increments of 5 milliamps while observing the response. When the response no longer increases with further current increase, that is the maximal current. Supramaximal current is then set at 20-25 percent above this level. Typical supramaximal current is 40-60 milliamps, though it may be higher in obese patients or those with peripheral oedema."

---

Examiner: "At the end of surgery, your monitor shows TOF ratio of 0.85. The surgeon is keen to finish. What do you do?"

Candidate: "A TOF ratio of 0.85 indicates residual neuromuscular blockade. The accepted criterion for safe extubation is TOF ratio greater than or equal to 0.9. At a ratio of 0.85, the patient is at increased risk of upper airway obstruction, aspiration from impaired swallowing, and reduced hypoxic ventilatory response.

I would not proceed to extubation at this stage. Instead, I would administer a reversal agent. Since the TOF ratio is 0.85 with four visible twitches, this represents light residual block that would respond well to either neostigmine or sugammadex.

For rapid reversal, I would choose sugammadex 2 mg/kg, which would achieve TOF ratio greater than 0.9 within 1-3 minutes.

Alternatively, neostigmine 40-50 micrograms per kilogram with glycopyrrolate would be appropriate, though recovery would take 10-15 minutes.

Regardless of which agent I use, I would continue monitoring and only proceed to extubation when the quantitative monitor confirms TOF ratio of at least 0.9. I would explain to the surgeon that this brief delay is necessary for patient safety."

---

Examiner: "Why can't you just do a head lift test or look at tidal volumes instead of using the monitor?"

Candidate: "Clinical tests such as head lift, grip strength, and tidal volume assessment are unreliable indicators of adequate neuromuscular recovery for several important reasons.

First, these tests require patient cooperation and sufficient arousal from anaesthesia, which may not be present during emergence. A patient who cannot follow commands cannot demonstrate a head lift.

Second, and most importantly, clinical tests cannot reliably detect residual block when the TOF ratio is between 0.7 and 0.9. Studies have shown that patients can perform a 5-second head lift and have apparently normal tidal volumes while still having clinically significant residual paralysis with TOF ratios in this range.

Third, visual and tactile assessment of TOF fade cannot detect fade when the ratio exceeds 0.4. So even if I observed the response to nerve stimulation without a quantitative monitor, I could not reliably distinguish a ratio of 0.7 from 0.95.

The evidence clearly shows that residual block with TOF ratio 0.7-0.9 is associated with a four-fold increase in critical respiratory events including airway obstruction, hypoxaemia, and need for reintubation. This is why all current guidelines recommend quantitative monitoring with documented TOF ratio of at least 0.9 before extubation.

Using clinical signs alone results in residual block in 20-40 percent of patients at extubation. This is unacceptable when quantitative monitoring is available and can reduce this rate to less than 5 percent."

---

Examiner: "What are the limitations of acceleromyography compared to mechanomyography?"

Candidate: "While acceleromyography is the practical clinical standard, it has several limitations compared to mechanomyography, which remains the gold standard.

First, AMG requires free thumb movement. The hand must be positioned with the thumb able to adduct without obstruction. If the arm is tucked under drapes or positioned where the thumb cannot move freely, AMG cannot be used at that site.

Second, AMG can be affected by positioning changes. If the hand adapter shifts during surgery or the sensor position changes, readings may become inconsistent.

Third, and importantly, AMG tends to overestimate recovery compared to mechanomyography. An AMG TOF ratio of 1.0 may correspond to a mechanomyography ratio of only 0.9. This is because acceleration is influenced by factors beyond muscle force, and the calculation algorithms may introduce systematic differences. For this reason, some authorities recommend using a higher threshold for AMG, such as 0.95 or 1.0, or using the normalised ratio that compares current response to the pre-NMBA baseline.

Fourth, AMG requires calibration before neuromuscular blocking agent administration. If calibration is not performed or if it drifts during a long procedure, the absolute TOF ratio values may be less reliable.

In contrast, mechanomyography directly measures isometric force of contraction, which is what we truly want to know. It is highly reproducible and accurate, which is why it remains the reference method for research. However, MMG requires complex setup taking 15-20 minutes, bulky equipment, and rigid arm fixation—making it impractical for routine clinical use.

Despite its limitations, AMG provides vastly better information than qualitative assessment alone and represents a reasonable compromise between accuracy and practicality."

---

References

1. Ali HH, Savarese JJ. Monitoring of neuromuscular function. Anesthesiology. 1976;45(2):216-249. PMID: 782269

2. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997;86(4):765-771. PMID: 9105219

3. Brull SJ, Kopman AF. Current status of neuromuscular reversal and monitoring: Challenges and opportunities. Anesthesiology. 2017;126(1):173-190. PMID: 27820709

4. Murphy GS, Brull SJ. Residual neuromuscular block: Lessons unlearned. Part I: Definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111(1):120-128. PMID: 20442260

5. Naguib M, Brull SJ, Kopman AF, et al. Consensus statement on perioperative use of neuromuscular monitoring. Anesth Analg. 2018;127(1):71-80. PMID: 29200077

6. Fortier LP, McKeen D, Turner K, et al. The RECITE study: A Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg. 2015;121(2):366-372. PMID: 25902322

7. Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular block and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107(1):130-137. PMID: 18635478

8. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans. Anesthesiology. 1997;87(5):1035-1043. PMID: 9366453

9. Sundman E, Witt H, Olsson R, et al. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Anesthesiology. 2000;92(4):977-984. PMID: 10754616

10. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: A meta-analysis. Br J Anaesth. 2007;98(3):302-316. PMID: 17307778

11. Cammu G, De Witte J, De Veylder J, et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg. 2006;102(2):426-429. PMID: 16428537

12. Lee CM. Train-of-4 quantitation of competitive neuromuscular block. Anesth Analg. 1975;54(5):649-653. PMID: 1237250

13. Viby-Mogensen J, Howardy-Hansen P, Chraemmer-Jørgensen B, et al. Posttetanic count (PTC): A new method of evaluating an intense nondepolarizing neuromuscular blockade. Anesthesiology. 1981;55(4):458-461. PMID: 6116461

14. Ali HH, Utting JE, Gray C. Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth. 1970;42(11):967-978. PMID: 4320284

15. Bonsu AK, Viby-Mogensen J, Fernando PU, et al. Relationship of post-tetanic count and train-of-four response during intense neuromuscular blockade caused by atracurium. Br J Anaesth. 1987;59(9):1089-1092. PMID: 2888503

16. Fernando PU, Viby-Mogensen J, Bonsu AK, et al. Relationship between posttetanic count and response to carinal stimulation during vecuronium-induced neuromuscular blockade. Acta Anaesthesiol Scand. 1987;31(7):593-596. PMID: 2889474

17. El-Orbany MI, Joseph NJ, Salem MR. The relationship of posttetanic count and train-of-four responses during recovery from intense cisatracurium-induced neuromuscular blockade. Anesth Analg. 2003;97(1):80-84. PMID: 12818947

18. Engbaek J, Ostergaard D, Viby-Mogensen J. Double burst stimulation (DBS): A new pattern of nerve stimulation to identify residual neuromuscular block. Br J Anaesth. 1989;62(3):274-278. PMID: 2522790

19. Drenck NE, Ueda N, Olsen NV, et al. Manual evaluation of residual curarization using double burst stimulation: A comparison with train-of-four. Anesthesiology. 1989;70(4):578-581. PMID: 2648890

20. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. Acta Anaesthesiol Scand. 1997;41(9):1095-1103. PMID: 9366929

21. Butterly A, Bittner EA, George E, et al. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010;105(3):304-309. PMID: 20576632

22. Lee C. Succinylcholine: its past, present and future. In: Katz RL, ed. Muscle Relaxants: Basic and Clinical Aspects. Orlando: Grune & Stratton; 1985:69-85.

23. Martini CH, Boon M, Beber SJ, et al. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth. 2014;112(3):498-505. PMID: 24240315

24. Madsen MV, Staehr-Rye AK, Gätke MR, Claudius C. Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review. Acta Anaesthesiol Scand. 2015;59(1):1-16. PMID: 25312684

25. Drenck NE, Ueda N, Olsen NV, et al. Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four. Anesthesiology. 1989;70(4):578-581. PMID: 2648890

26. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. Anesthesiology. 1991;74(5):833-837. PMID: 1673591

27. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology. 2010;112(4):1013-1022. PMID: 20234315

28. Thilen SR, Weigel WA, Todd MM, et al. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade. Anesthesiology. 2023;138(1):13-41. PMID: 36520073

29. Naguib M, Brull SJ, Kopman AF, et al. Consensus statement on perioperative use of neuromuscular monitoring. Anesth Analg. 2018;127(1):71-80. PMID: 29200077

30. Claudius C, Viby-Mogensen J. Acceleromyography for use in scientific and clinical practice: A systematic review of the evidence. Anesthesiology. 2008;108(6):1117-1140. PMID: 18497614

31. Murphy GS, Szokol JW, Avram MJ, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology. 2011;115(5):946-954. PMID: 21946094

32. Liang SS, Stewart PA, Phillips S. An ipsilateral comparison of acceleromyography and electromyography during recovery from nondepolarizing neuromuscular block under general anesthesia in humans. Anesth Analg. 2013;117(2):373-379. PMID: 23757472

33. Hemmerling TM, Le N. Brief review: Neuromuscular monitoring: An update for the clinician. Can J Anaesth. 2007;54(1):58-72. PMID: 17197470

34. Viby-Mogensen J, Jensen E, Werner M, Nielsen HK. Measurement of acceleration: A new method of monitoring neuromuscular function. Acta Anaesthesiol Scand. 1988;32(1):45-48. PMID: 2830760

35. Capron F, Alla F, Hottier C, et al. Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology. 2004;100(5):1119-1124. PMID: 15114208

36. Fuchs-Buder T, Claudius C, Skovgaard LT, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: The Stockholm revision. Acta Anaesthesiol Scand. 2007;51(7):789-808. PMID: 17635389

37. Heier T, Caldwell JE, Sessler DI, Miller RD. Mild intraoperative hypothermia increases duration of action and spontaneous recovery of vecuronium blockade during nitrous oxide-isoflurane anesthesia in humans. Anesthesiology. 1991;74(5):815-819. PMID: 1673589

38. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: A meta-analysis. Br J Anaesth. 2007;98(3):302-316. PMID: 17307778

39. Murphy GS, Szokol JW, Avram MJ, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology. 2011;115(5):946-954. PMID: 21946094

40. Kirmeier E, Eriksson LI, Lewald H, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. Lancet Respir Med. 2019;7(2):129-140. PMID: 30224322

41. Fortier LP, McKeen D, Turner K, et al. The RECITE study: A Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade. Anesth Analg. 2015;121(2):366-372. PMID: 25902322

---

This content is designed for ANZCA Primary and Final Examination preparation. Always verify current guidelines and local protocols.